Is clinician impression of depression symptom severity associated with incremental economic burden in privately insured US patients with treatment resistant depression?

•Increased severity status was associated with incremental burden in patients with TRD.•Inpatient admissions and outpatient visits were key drivers of incremental costs.•Pharmacotherapy use was similar across the severity cohorts.